Clinical Trial: Travoprost Intraocular Implant + iStent Infinite vs. iStent Infinite Alone

Study Status: RECRUITING
Recruit Status: RECRUITING
Study Type: INTERVENTIONAL

Official Title: Multicenter, Randomized, Double-masked Trial to Evaluate the Safety and Efficacy of iDose� TR (Travoprost Intraocular Implant) in Conjunction With the Placement of iStent Infinite vs. iStent Infinite

Brief Summary: Adult subjects with elevated intraocular pressure who have successfully undergone placement of iStent infinite trabecular bypass system will be randomized to receive a travoprost intraocular implant or receive a sham procedure and be followed for 12 months.

Detailed Summary:
Sponsor: Glaukos Corporation

Current Primary Outcome: mean diurnal IOP at the 3 month visit minus mean diurnal IOP at baseline

Original Primary Outcome: mean diurnal IOP at the 3 month visit minus mean diurnal IOP at baseline

Current Secondary Outcome:

Original Secondary Outcome:

Information By: Glaukos Corporation

Dates:
Date Received: September 27, 2023
Date Started: September 14, 2023
Date Completion: September 14, 2023
Last Updated: September 27, 2023
Last Verified: September 01, 2023